Furthermore, given PTX3’s pivotal role in inflammation and tissue repair, especially in bone remodeling, cancer patients with bone metastases may benefit from PTX3 inhibition, or even TNF-α inhibition (66, 102), an area that warrants further exploration. The gene discussed is TNF; the disease is cancer.